The latest announcement is out from Tribeca Global Natural Resources Ltd. ( ($AU:TGF) ). Tribeca Global Natural Resources Ltd. announced the ...
Tribeca Global Natural Resources Ltd. ( ($AU:TGF) ) just unveiled an update. Tribeca Global Natural Resources Ltd. has announced an update ...
Discusses ESMO Data on TGF-beta Receptor by PD-1 Bispecific in Colorectal Cancer and G12D Inhibitor in Pancreatic ...
Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies ...
The tender offer will expire at 5:00 p.m. ET on Tuesday, November 18, 2025, unless extended or earlier terminated. The full terms, conditions and other details of the tender offer are set forth in the ...
Gyre Therapeutics (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today ...
Agrees to Repurchase of All Shares Held By ADAR1 Capital Management and Pontifax Venture CapitalPlans to Commence Tender Offer to Repurchase up ...
A recent study published in Life Metabolism by researchers from the Affiliated Hospital of Nantong University has identified ...
The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...
Ficerafusp alfa is currently being evaluated in FORTIFI-HN01, a pivotal Phase 2/3 clinical trial in patients with first line (1L) recurrent/metastatic (R/M) head and neck squamous cell carcinoma ...
Data from Incyte’s TGFβR2×PD-1 Bispecific Antibody and KRAS G12D Inhibitor to be Presented at the ESMO Congress 2025 ...
Animal bones are full of collagen, calcium, and minerals—and are even more nutritious than meat. We asked food scientists how to make them part of your diet. There’s more value in bones than collagen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results